Risk assessment of GBL as a substitute for the illicit drug GHB in the Netherlands. A comparison of the risks of GBL versus GHB.

van Amsterdam, Jan; Brunt, Tibor; Pennings, Ed; van den Brink, Wim

van Amsterdam, Jan; Brunt, Tibor; Pennings, Ed; van den Brink, Wim.

Afiliação

van Amsterdam J; Amsterdam Institute for Addiction Research, Academic Medical Center University of Amsterdam, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands; Amsterdam Institute for Addiction Research, Academic Medical Center, P.O. Box 75867, 1070 AW Amsterdam, The Netherlands. Electronic address: jan.van.amster
Brunt T; Trimbos Institute (Netherlands Institute of Mental Health and Addiction), Da Costakade 45, 3521 VS Utrecht, The Netherlands.
Pennings E; The Maastricht Forensic Institute, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
van den Brink W; Amsterdam Institute for Addiction Research, Academic Medical Center University of Amsterdam, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands; Amsterdam Institute for Addiction Research, Academic Medical Center, P.O. Box 75867, 1070 AW Amsterdam, The Netherlands.

Regul Toxicol Pharmacol ; 70(2): 507-13, 2014 Nov.

Article em En | MEDLINE | ID: mdl-25204614

Assuntos

4-Butirolactona/efeitos adversos; Hidroxibutiratos/efeitos adversos; Drogas Ilícitas/efeitos adversos; Animais; Overdose de Drogas; Europa (Continente); Humanos; Países Baixos; Risco; Medição de Risco

Palavras-chave

Addiction; Illicit drugs; Legislation; Risk assessment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: 4-Butirolactona / Drogas Ilícitas / Hidroxibutiratos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Animals / Humans País/Região como assunto: Europa Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google